Overview

Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects

Status:
Completed

Trial end date:
2011-08-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the bioavailability of 0.5mg dutasteride novel formulation compared to the currently marketed 0.5mg dutasteride soft gel capsule in fasted healthy male subjects.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Dutasteride